相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Metabias: A Challenge for Comparative Effectiveness Research
Steven Goodman et al.
ANNALS OF INTERNAL MEDICINE (2011)
Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia
Phillip Scheinberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Subcutaneous alemtuzumab plus cyclosporine for the treatment of aplastic anemia
David Gomez-Almaguer et al.
ANNALS OF HEMATOLOGY (2010)
Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA
Antonio Maria Risitano et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents
Carlo Piccinni et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Paroxysmal nocturnal hemoglobinuria clones in severe aplastic anemia patients treated with horse anti-thymocyte globulin plus cyclosporine
Phillip Scheinberg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
David B. Clifford et al.
LANCET NEUROLOGY (2010)
Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases (vol 9, pg 438, 2010)
D. B. Clifford et al.
LANCET NEUROLOGY (2010)
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Kenneth R. Carson et al.
BLOOD (2009)
Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study
Phillip Scheinberg et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Granulocyte transfusions in severe aplastic anemia: an eleven-year experience
Karen Quillen et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
A pilot dose-escalating study of alemtuzumab plus cyclosporine for patients with bone marrow failure syndrome
Hawk Kim et al.
LEUKEMIA RESEARCH (2009)
Alemtuzumab for the treatment of steroid-refractory acute graft-versus-host disease
David Gomez-Almaguer et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2008)
Monoclonal antibodies for the treatment of hematologic malignancies: Schedule and maintenance therapy
Alden Moccia et al.
SEMINARS IN HEMATOLOGY (2008)
Why Current Publication Practices May Distort Science
Neal S. Young et al.
PLOS MEDICINE (2008)
Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia
Phillip Scheinberg et al.
BLOOD (2007)
Current concepts in the pathophysiology and treatment of aplastic anemia
Neal S. Young et al.
BLOOD (2006)
Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia
P Scheinberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil
P Scheinberg et al.
BRITISH JOURNAL OF HAEMATOLOGY (2006)
Autoimmune thyroid disease after renal transplantation using depletional induction with alemtuzumab
AD Kirk et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
The epidemiology of aplastic anemia in Thailand
S Issaragrisil et al.
BLOOD (2006)
Allogeneic stem-cell transplantation using a reduced-intensity conditioning regimen has the capacity to produce durable remissions and long-term disease-free survival in patients with high-risk acute myeloid leukemia and myelodysplasia
S Tauro et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Multiple sclerosis and Hashimoto thyroiditis -: Two cases
B Petek-Balci et al.
NEUROLOGIST (2005)
A third course of anti-thymocyte globulin in aplastic anaemia is only beneficial in previous responders
V Gupta et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Cardiac toxicity of alemtuzumab in patients with mycosis fungoides/Sezary syndrome
DJ Lenihan et al.
BLOOD (2004)
Reactivation of latent Epstein-Barr virus by methotrexate: A potential contributor to methotrexate-associated lymphomas
WH Feng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Recombinant humanized anti-IL-2 receptor antibody (daclizumab) produces responses in patients with moderate aplastic anemia
JP Maciejewski et al.
BLOOD (2003)
Clinical trial of quantitative real-time polymerase chain reaction for detection of cytomegalovirus in peripheral blood of allogeneic hematopoietic stem-cell transplant recipients
KJ Cortez et al.
JOURNAL OF INFECTIOUS DISEASES (2003)
Antithymocyte globulin and cyclosporine for severe aplastic anemia - Association between hematologic response and long-term outcome
S Rosenfeld et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia
RA Brodsky et al.
ANNALS OF INTERNAL MEDICINE (2001)
The effect of treatment with Campath-1H in patients with autoimmune cytopenias
F Willis et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
High-dose cyclophosphamide in severe aplastic anaemia: a randomised trial
JF Tisdale et al.
LANCET (2000)
Campath-1H therapy in refractory ocular inflammatory disease
AD Dick et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2000)
分享论文
